During the Trading Day
| 54.72 |  +0.09 / +0.16% |
Data as of 3:59pm ET | Day’s Change | |
| 54.73 | +0.0109 / +0.02% |
| Volume: 1.4K |
| SECTOR Health Technology | INDUSTRY Medical Specialties | MARKET CAP $1.3B |
Company Description
Neogen Corp. engages in the development, manufacture and sale of various products for food safety testing and animal health applications. The company operates through two segments: Food Safety and Animal Safety. The Food Safety segment develops and markets dehydrated culture media and rapid diagnostic test kits to detect foodborne bacteria, spoilage organisms, mycotoxins, food allergens, genetic modifications, drug residues, plant diseases and sanitation concerns. The Animal Safety segment develops and markets a complete line of diagnostics, veterinary instruments, veterinary pharmaceuticals, nutritional supplements, disinfectants and rodenticides. The company was founded in June 1981 and is headquartered in Lansing, MI.
Employees
Shareholders
| Individual stakeholders | 7.52% |
| Other institutional | 52.67% |
| Mutual fund holders | 29.59% |
Top Executives
| James L. Herbert | Chairman & Chief Executive Officer |
| Lon M. Bohannon, CPA | President, Chief Operating Officer & Director |
| Steven J. Quinlan, MBA, CPA | Chief Financial Officer & Vice President |
| Joseph M. Madden, PhD | Vice President-Scientific Affairs |
| Mark A. Mozola, PhD | Vice President-Research & Development |
.
